Special considerations / additional information Continued over page Special considerations / additional information (continued)
|Ensure there is immediate access to adrenaline (epinephrine) 1 in 1,000 injection and access to a telephone at the time of vaccination. |
Minor illnesses without fever or systemic upset are not valid reasons to postpone vaccination. If an individual is acutely unwell, vaccination should be postponed until they have fully recovered.
Women of child-bearing age, currently pregnant, planning a pregnancy or breastfeeding As with most pharmaceutical products, specific clinical trials in pregnant women have not been carried out for this vaccine. Because of the new formulation of this particular vaccine, the MHRA wants to see more non-clinical data before finalising the advice in pregnancy. It is standard practice when waiting for such data on any medicine, to avoid its use in those who may become pregnant or who are breastfeeding. Women should be advised that they should not receive a COVID-19 vaccine if they are breastfeeding, pregnant, may be pregnant or are planning a pregnancy. Vaccination should be postponed until completion of pregnancy and, if relevant, until finished breastfeeding. Pregnancy should be avoided until 2 months after the second dose of vaccine.
doorklikken op: https://assets.publishing.service.gov.uk/…/20201217…